VisionQuest i-Rx has penetrated key markets through our implementation of a diabetic retinopathy screening program in New Mexico, where the company has contracts with the four major payors in the state. VisionQuest i-Rx’s screening solution starts with the primary care physician, who orders the test using their panel of standard tests for diabetics. Patients with diabetes then go to a reference laboratory where retinal images are collected at the same time as blood draws are performed. The retinal images are automatically uploaded to VisionQuest i-Rx’ picture archival and communications system (PACS). Licensed optometrists read the cases; those requiring follow-up with an ophthalmologist are automatically referred to Eye Associates of New Mexico, the largest ophthalmology practice in the state.

The implementation of this early generation of the EYESTAR™ system has demonstrated all of the components of a successful diabetic retinopathy screening system and provided needed clinical validation for the U.S. market FDA clearance effort.

The international market for EYESTAR™ automated screening system is being validated at Clinicas del Azucar, a network of diabetic clinics in Monterrey, Mexico. Clinicas del Azucar provides comprehensive diabetic care for a fixed annual fee, including retinal evaluations that VisionQuest i-Rx has provided since 2012.

In October 2015, VisionQuest i-Rx received Mexican regulatory clearance allowing providers in Mexico, including Clinicas del Azucar, to use EYESTAR™ automated reading system as part of their diabetes clinic flow. In February 2016, VisionQuest i-Rx integrated the EYESTAR™ automated screening system as part of Clinicas del Azucar’s standard of care for diabetic retinopathy screening. To date, more than 5,000 patients have been screening using the EYESTAR™ system. Our technology is one of the key enablers for the Clinicas del Azucar’s expansion plans.